SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 64 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $27,826,000 | +16.3% | 2,303,462 | -20.0% | 11.83% | +74.1% |
| Q4 2014 | $23,927,000 | -4.4% | 2,879,328 | 0.0% | 6.80% | -54.6% |
| Q3 2014 | $25,021,000 | -36.4% | 2,879,328 | -20.0% | 14.96% | -18.2% |
| Q2 2014 | $39,348,000 | +22.4% | 3,600,000 | 0.0% | 18.28% | +3.1% |
| Q1 2014 | $32,148,000 | +18.6% | 3,600,000 | 0.0% | 17.74% | -13.2% |
| Q4 2013 | $27,108,000 | +2.9% | 3,600,000 | 0.0% | 20.43% | +36.0% |
| Q3 2013 | $26,352,000 | +13.7% | 3,600,000 | 0.0% | 15.02% | -15.8% |
| Q2 2013 | $23,184,000 | – | 3,600,000 | – | 17.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |